Effects of Coadministration of Empagliflozin and Colchicine on Heart Failure.

Phase 3

Recruiting

• Conditions: Heart failure.; Systolic (congestive) heart failure; I50.2

• Registration Number: IRCT20111206008307N40
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Heart Failure with Reduced Ejection Fraction
Aged 18 to 80 years
Consented patients

Exclusion Criteria

Pregnancy
Lactation
Liver failure
Kidney failure
Systolic blood pressure less than 100 or more than 180 mm Hg
Diabetes mellitus
Malignancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life score in KCCQ questionnaire. Timepoint: The beginning of the study and months 3 and 6. Method of measurement: KCCQ questionnaire.